The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment
Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes
The Semaglutide Treatment Effect in People with obesity (STEP) program, a phase III randomized clinical trial (RCT), was conducted in patients with T2D, obesity, and various metabolic disorders
Metformin Published clinical lactation studies report that metformin is present in human milk, which resulted in infant doses approximately 0.11% to 1% of the maternal weight-adjusted dosage and a milk/plasma ratio ranging between 0.13 and 1
is manufactured by Kuhnil Biopharm Co., Ltd
These reactions are generally mild and self-limiting